Winde G - Search Results

1

Sulindac sulfide inhibits Ras signaling.

Herrmann C, Block C, Geisen C, Haas K, Weber C, Winde G, Möröy T, Müller O. Herrmann C, et al. Among authors: winde g. Oncogene. 1998 Oct 8;17(14):1769-76. doi: 10.1038/sj.onc.1202085. Oncogene. 1998. PMID: 9778042

2

The new sulindac derivative IND 12 reverses Ras-induced cell transformation.

Karaguni IM, Herter P, Debruyne P, Chtarbova S, Kasprzynski A, Herbrand U, Ahmadian MR, Glüsenkamp KH, Winde G, Mareel M, Möröy T, Müller O. Karaguni IM, et al. Among authors: winde g. Cancer Res. 2002 Mar 15;62(6):1718-23. Cancer Res. 2002. PMID: 11912145

3

New indene-derivatives with anti-proliferative properties.

Karaguni IM, Glüsenkamp KH, Langerak A, Geisen C, Ullrich V, Winde G, Möröy T, Müller O. Karaguni IM, et al. Among authors: winde g. Bioorg Med Chem Lett. 2002 Feb 25;12(4):709-13. doi: 10.1016/s0960-894x(01)00839-3. Bioorg Med Chem Lett. 2002. PMID: 11844707

4

SMAF-1 inhibits the APC/beta-catenin pathway and shows properties similar to those of the tumor suppressor protein APC.

Karaguni IM, Gourzoulidou E, Carpintero M, Langerak A, Klein-Hitpass L, Möröy T, Winde G, Waldmann H, Müller O. Karaguni IM, et al. Among authors: winde g. Chembiochem. 2004 Sep 6;5(9):1267-70. doi: 10.1002/cbic.200400078. Chembiochem. 2004. PMID: 15368578 No abstract available.

5

Clinical and genomic influence of sulindac on rectal mucosa in familial adenomatous polyposis.

Winde G, Schmid KW, Brandt B, Müller O, Osswald H. Winde G, et al. Dis Colon Rectum. 1997 Oct;40(10):1156-68; discussion 1168-9. doi: 10.1007/BF02055161. Dis Colon Rectum. 1997. PMID: 9336110 Clinical Trial.

6

Decreased HER-2 tyrosine kinase expression in rectal mucosa of FAP patients following low-dose sulindac chemoprevention.

Winde G, Lügering N, Glodny B, Schmid KW, Müller O, Senninger N, Osswald H. Winde G, et al. Cancer Lett. 1998 Dec 25;134(2):201-7. doi: 10.1016/s0304-3835(98)00254-7. Cancer Lett. 1998. PMID: 10025882

7

DNA alterations in sporadic colorectal tumors do not correlate with tumor staging diagnosed by the TNM system.

Deuter R, Linz J, Pietsch S, Winde G, Hentsch S, Müller O. Deuter R, et al. Among authors: winde g. Cancer Lett. 1996 Dec 3;109(1-2):161-9. doi: 10.1016/s0304-3835(96)04441-2. Cancer Lett. 1996. PMID: 9020916

8

Loss of the PLA2G2A gene in a sporadic colorectal tumor of a patient with a PLA2G2A germline mutation and absence of PLA2G2A germline alterations in patients with FAP.

Nimmrich I, Friedl W, Kruse R, Pietsch S, Hentsch S, Deuter R, Winde G, Müller O. Nimmrich I, et al. Among authors: winde g. Hum Genet. 1997 Sep;100(3-4):345-9. doi: 10.1007/s004390050514. Hum Genet. 1997. PMID: 9272153

9

Non-invasive detection of colorectal tumours by the combined application of molecular diagnosis and the faecal occult blood test.

Kutzner N, Hoffmann I, Linke C, Thienel T, Grzegorczyk M, Urfer W, Martin D, Winde G, Traska T, Hohlbach G, Müller KM, Kuhnen C, Müller O. Kutzner N, et al. Among authors: winde g. Cancer Lett. 2005 Nov 8;229(1):33-41. doi: 10.1016/j.canlet.2004.12.011. Epub 2005 Jan 18. Cancer Lett. 2005. PMID: 16157216 Clinical Trial.

10

Activation of extracellular regulated kinases (ERK1/2) but not AKT predicts poor prognosis in colorectal carcinoma and is associated with k-ras mutations.

Schmitz KJ, Wohlschlaeger J, Alakus H, Bohr J, Stauder MA, Worm K, Winde G, Schmid KW, Baba HA. Schmitz KJ, et al. Among authors: winde g. Virchows Arch. 2007 Feb;450(2):151-9. doi: 10.1007/s00428-006-0342-y. Virchows Arch. 2007. PMID: 17149612

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

96 results

Search Page